First Squawk
@FirstSquawk
Firstsquawk Is a Global Financial (News) Squawk Service Specialising In Financial Markets, Macro, Geopolitics,politics
Joined July 2015
251 Following 567.8K Followers
U.S. regulators grant accelerated approval to Bayer’s sevabertinib as a first-line targeted therapy for HER2-mutated NSCLC.
